Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study-Reference-Cited by-同舟云学术

Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study

Published:2022-06-21 Issue:7 Volume:16 Page:673-680
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Zhao Guang Sheng¹,Liu Song²,Liu Ying³,Li Chuang¹,Wang Ruo Yu⁴,Bian Jie⁵,Zhang Yue Wei³,Zhou Jun¹,Lin Ya Jie⁵,Wu Jianlin⁶

Affiliation:

1. Minimally Invasive Interventional Diagnosis and Treatment Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China

2. Interventional Medicine Center, Linyi Cancer Hospital, Linyi, Shandong Province, China

3. Hepatobiliary and Pancreatic Center, Beijing Tsinghua Changgung Hospital, Beijing, Changping District, China

4. Cancer Treatment Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China

5. Department of Ultrasound, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China

6. Department of Radiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning Province, China

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2022.2091545

Reference31 articles.

1. Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus

2. A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus

3. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement

4. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition

5. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma: A tertiary center experience;Pakistan Journal of Medical Sciences;2024-05-21

2. Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study;BMC Cancer;2023-10-25

3. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus;European Radiology;2023-07-12